Executive Chairman David Schlanger Sells 66,002 Shares of Progyny Inc
Executive Chairman David Schlanger sold 66,002 shares of Progyny Inc (NASDAQ:PGNY) on January 8, 2024, according to a recent SEC Filing. The transaction was executed at an average price of $37.88 per share, resulting in a total sale amount of $2,499,915.76.
Progyny Inc is a company that provides fertility and family building benefits solutions in the United States. The company offers fertility treatment services, including in vitro fertilization, egg freezing, and other fertility preservation technologies. Progyny's comprehensive benefits solutions are designed to meet the needs of self-insured employers, helping them to provide their employees with access to a network of fertility specialists and personalized treatment plans.
Over the past year, the insider has sold a total of 1,400,000 shares and has not made any purchases. The recent sale by the insider is part of a trend observed over the past year, where there have been no insider buys and 44 insider sells for Progyny Inc.
On the valuation front, Progyny Inc's shares were trading at $37.88 on the day of the insider's sale, giving the company a market capitalization of $3.627 billion. The price-earnings ratio stands at 72.79, which is above the industry median of 27.59 but below the company's historical median price-earnings ratio.
The stock's price-to-GF-Value ratio is 0.47, with a GF Value of $80.95, indicating that Progyny Inc is significantly undervalued according to GuruFocus's intrinsic value estimate. The GF Value is determined by historical trading multiples, a GuruFocus adjustment factor based on past returns and growth, and future business performance estimates from Morningstar analysts.
Investors and analysts often monitor insider transactions as they can provide insights into a company's internal perspective on the stock's valuation and future prospects. The recent sale by Executive Chairman David Schlanger may attract attention from the market as stakeholders evaluate the implications of this insider activity.
This article, generated by GuruFocus, is designed to provide general insights and is not tailored financial advice. Our commentary is rooted in historical data and analyst projections, utilizing an impartial methodology, and is not intended to serve as specific investment guidance. It does not formulate a recommendation to purchase or divest any stock and does not consider individual investment objectives or financial circumstances. Our objective is to deliver long-term, fundamental data-driven analysis. Be aware that our analysis might not incorporate the most recent, price-sensitive company announcements or qualitative information. GuruFocus holds no position in the stocks mentioned herein.
This article first appeared on GuruFocus.
